Pituitary hypoplasia and growth hormone deficiency in a patient with Coffin-Siris syndrome and severe short stature: case report and literature review
Abstract
##plugins.themes.bootstrap3.article.details##
Coffin-Siris syndrome, BAF remodeling complex, short stature, GH deficiency, CNS malformations
2. Lopez AJ, Wood MA. Role of nucleosome remodeling in neurodevelopmental and intellectual disability disorders. Front Behav Neurosci. 2015;9:100
3. Coffin GS, Siris E. Mental retardation with absent fifth fingernail and terminal phalanx. Am J Dis Child. 1970; 119:433–439.
4. Fleck BJ, Pandya A, Vanner L, Kerkering K, Bodurtha J. Coffin‐Siris syndrome: Review and presentation of new cases from a questionnaire study. Am J Med Genet. 2001; 99(1):1-7
5. Vergano SA, Sluijs PJ van der, Santen G. ARID1B-Related Disorder. 2019. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle: University of Washington, Seattle: 1993-2022.
6. Vasko A, Schrier Vergano SA. Language impairments in individuals with Coffin-Siris syndrome. Front Neurosci. 2022; 15: 802583.
7. Schrier SA, Bodurtha JN, Burton B, et al. The Coffin-Siris syndrome: a proposed diagnostic approach and assessment of 15 overlapping cases. Am J Med Genet A. 2012; 158A:1865–1876.
8. Baban A, Moresco L, Divizia MT, et al. Pituitary hypoplasia and growth hormone deficiency in Coffin-Siris syndrome. Am J Med Genet A. 2008; 146A:384–388.
9. Pascanu I, Pop R, Barbu CG, et al. Endocrine care development of synthetic growth charts for Romanian population. Acta Endocrinol. 2016; XII:309–318.
10. World Health Organisation. WHO Child growth standards: Height-for-age girls 2 to 5 years (percentiles).[https://cdn.who.int/media/docs/default-source/child-growth/child-growth-standards/indicators/length-height-for-age/hfa-girls-2-5-percentiles.pdf?sfvrsn=adc3b954_7]
11. Yau M, Rapaport R. Growth hormone stimulation testing: to test or not to test? That is one of the questions. Front Endocrinol (Lausanne). 2022; 0:1099.
12. Caputo M, Pigni S, Agosti E, et al. Regulation of GH and GH signaling by nutrients. Cells. 2021; 10(6):1376
13. Hawkes CP, Grimberg A, Dzata VE, De Leon DD. Adding glucagon stimulated GH testing to the diagnostic fast increases the detection of GH sufficient children. Horm Res Paediatr. 2016; 85(4):265-272.
14. Seaver LH, Irons M. ACMG practice guideline: Genetic evaluation of short stature. Genet Med. 2009;11:465.
15. Preda C, Ungureanu MC, Leustean L, Cristea C, Vulpoi C. Ethical issues related to the use of human growth hormone in idiopathic short stature. Revista Romana de Bioetica 2013; 11(4): 31-37.
16. Dauber A, Rosenfeld RG, Hirschhorn JN. Clinical Review: Genetic evaluation of short stature. J Clin Endocrinol Metab. 2014; 99:3080.
17. Alfert A, Moreno N, Kerl K. The BAF complex in development and disease. Epigenetics Chromatin 2019. 2019; 12:1–15.
18. Miyake N, Tsurusaki Y, Matsumoto N. Numerous BAF complex genes are mutated in Coffin-Siris syndrome. Am J Med Genet C Semin Med Genet. 2014; 166C:257–261.
19. Sim JCH, White SM, Lockhart PJ. ARID1B-mediated disorders: Mutations and possible mechanisms. Intractable Rare Dis Res. 2015;4:17–23
20. Yu Y, Yao RE, Wang L, et al. De novo mutations in ARID1B associated with both syndromic and non-syndromic short stature. BMC Genomics. 2015; 16:1–10.
21. Wright CF, Fitzgerald TW, Jones WD, et al. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet (London, England). 2015; 385:1305–1314.
22. Hoyer J, Ekici AB, Endele S, et al. Haploinsufficiency of ARID1B, a member of the SWI/SNF-a chromatin-remodeling complex, is a frequent cause of intellectual disability. Am J Hum Genet. 2012; 90(3):565-572.
23. van der Sluijs PJ, Jansen S, Vergano SA, et al. The ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin–Siris syndrome. Genet Med. 2019; 21(6):1295-1307.
24. Bögershausen N, Wollnik B. Mutational Landscapes and phenotypic spectrum of SWI/SNF-related intellectual disability disorders. Front Mol Neurosci. 2018; 11:252.
25. Machol K, Rousseau J, Ehresmann S, et al. Expanding the spectrum of BAF-related disorders: de novo variants in SMARCC2 cause a syndrome with intellectual disability and developmental delay. Am J Hum Genet. 2019; 104(1):164–178.
26. Zawerton A, Yao B, Yeager JP, et al. De novo SOX4 variants cause a neurodevelopmental disease associated with mild dysmorphism. Am J Hum Genet. 2019; 104(2):246-259.
27. Riley EP, Infante MA, Warren KR. Fetal alcohol spectrum disorders: an overview. Neuropsychol Rev. 2011; 21(2):73-80.
28. Vergano SS, Deardorff MA. Clinical features, diagnostic criteria, and management of Coffin-Siris syndrome. Am J Med Genet Part C Semin Med Genet. 2014; 166:252–256.
29. McCague EA, Lamichhane R, Holt N, Schrier Vergano SA. Growth charts for individuals with Coffin-Siris syndrome. Am J Med Genet Part A. 2020; 182:2253–2262.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.